The DOI matches its Crossref record; 542 of the 542 references it cites were found in a registry or an index.
The Glucagon-Like Peptides
Abstract
I. Introduction II. History of the Incretin Concept: Discovery of Gastric Inhibitory Polypeptide III. Discovery of GLP-1 IV. Structures of GLPs and Family of Glucagon-Related Peptides V. Tissue Distribution of the Expression of GLPs A. Pancreatic α-cells B. Intestinal L cells C. Central nervous system VI. Proglucagon Biosynthesis A. Organization/structure of the proglucagon gene B. Regulation of glucagon gene expression C. Posttranslational processing of proglucagon VII. Regulation of GLP Secretion A. Overview B. Intracellular signals C. Carbohydrates D. Fats E. Proteins F. Endocrine G. Neural H. GLP-2 VIII. Metabolism of GLPs A. GLP-1 B. GLP-2 IX. Physiological Actions of GLPs A. Overview B. Pancreatic islets C. Counterregulatory actions of GLP-1 and leptin on β-cells D. Stomach E. Lung F. Brain G. Liver, skeletal muscle, and fat H. Pituitary, hypothalamus, and thyroid I. Cardiovascular system J. GLP-2 X. GLP Receptors A. Structure B. Signaling C. Distribution D. Regulation E. GLP-2 XI. Pathophysiology o...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt
Potten, C. S., & Loeffler, M. (1990) · Development · doi:10.1242/dev.110.4.1001 · Cited by 1,791
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402
Reduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307
The mechanism of pancreatic secretion
Bayliss, W. M., & Starling, E. H. (1902) · The Journal of Physiology · doi:10.1113/jphysiol.1902.sp000920 · Cited by 1,269
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J., Potts, J. T., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249
Research works printed but not linked: 52
- Habener, 1993, The incretin notion and its relevance to diabetes. In: Vinik AI (ed) Gastrointestinal Hormones in Medicine., WB Saunders Company, Philadelphia, vol, 22, 775
- Zunz, 1929, Contributions a l’etude des variations physiologiques de la secretion interne du pancreas: realations entre les secretions externe et interne du pancreas., Arch Int Physiol Biochim, 31, 20
- Dixon, 1926, The action of intestinal extracts., Br Med J, 1, 820, 10.1136/bmj.1.3410.820 · doi:10.1136/bmj.1.3410.820
- Rabinovitch, 1972, Insulinotropic and glucagonotropic activities of crude preparation of cholecystokinin-pancreozymin., Clin Res, 20, 945
- Elahi, 1979, Pancreatic α- andβ -cell responses to GIP infusion in normal man, Am J Physiol, 237, E185
- Brown, 1976, GI hormones and insulin secretion. In: James VHT (ed) 5th International Congress on Endocrinology, Excerpta Medica, Hamburg, vol 2, 568
- Bunnett, 1986, Immunocytochemical localization of gastric inhibitory polypeptide and glucagon in the alimentary tract of ruminants., Q J Exp Physiol, 71, 433, 10.1113/expphysiol.1986.sp003002 · doi:10.1113/expphysiol.1986.sp003002
- Thomsen, 1972, The amino acid sequence of human glucagon., FEBS Lett, 21, 315, 10.1016/0014-5793(72)80192-3 · doi:10.1016/0014-5793(72)80192-3
- Sundby, 1974, Camel glucagon: isolation, crystallization and amino acid composition., Horm Metab Res, 6, 425, 10.1055/s-0028-1095723 · doi:10.1055/s-0028-1095723
- Sundby, 1972, Rabbit glucagon: isolation, crystallization and amino acid composition., Horm Metab Res, 4, 56, 10.1055/s-0028-1097080 · doi:10.1055/s-0028-1097080
- Bromer, 1971, Amino acid sequence of bovine glucagon., J Biol Chem, 246, 2822, 10.1016/S0021-9258(18)62256-2 · doi:10.1016/s0021-9258(18)62256-2
- Yu, 1989, Opossum insulin, glucagon and pancreatic polypeptide: amino acid sequences., Peptides, 10, 1195, 10.1016/0196-9781(89)90012-0 · doi:10.1016/0196-9781(89)90012-0
- Pollock, 1975, Isolation and amino acid sequence studies., J Biol Chem, 250, 9377, 10.1016/S0021-9258(19)40654-6 · doi:10.1016/s0021-9258(19)40654-6
- Markussen, 1972, Turkey glucagon: crystallization, amino acid composition and immunology., Horm Metab Res, 4, 360, 10.1055/s-0028-1094032 · doi:10.1055/s-0028-1094032
- Sundby, 1972, Crystallization and amino acid sequence of duck glucagon., FEBS Lett, 26, 289, 10.1016/0014-5793(72)80595-7 · doi:10.1016/0014-5793(72)80595-7
- Ferriera, 1991, Purification and primary structure of glucagon from ostrich pancreas splenic lobes., Int Pept Protein Res, 38, 90, 10.1111/j.1399-3011.1991.tb01415.x · doi:10.1111/j.1399-3011.1991.tb01415.x
- Conlon, 1990, Isolation and structural characterization of insulin, glucagon and somatostatin from the turtle, Psudemys scripta., Peptides, 11, 461, 10.1016/0196-9781(90)90043-5 · doi:10.1016/0196-9781(90)90043-5
- Cavanaugh, 1996, Isolation and structural characterization of proglucagon-derived peptides, pancreatic polypeptide, and somatostatin from the Urodele Amphiuma tridactylum., Gen Comp Endocrinol, 101, 12, 10.1006/gcen.1996.0003 · doi:10.1006/gcen.1996.0003
- Conlon, 1989, Multiple molecular forms of insulin and glucagon-like peptide from the Pacific ratfish (Hydrolagus colli)., Gen Comp Endocrinol, 73, 136, 10.1016/0016-6480(89)90064-6 · doi:10.1016/0016-6480(89)90064-6
- Berks, 1989, Isolation and structural characterization of insulin and glucagon from the holocephalan species Callorhynchus milii (elephantfish)., Biochem J, 263, 261, 10.1042/bj2630261 · doi:10.1042/bj2630261
- Conlon, 1993, Primary structures of glucagon and glucagon-like peptide isolated from the intestine of the parasitic phase lamprey Petromyzon marius., Gen Comp Endocrinol, 91, 96, 10.1006/gcen.1993.1109 · doi:10.1006/gcen.1993.1109
- Unger, 1961, Sites of origin of glucagon in dogs and humans., Clin Res, 9, 53
- Ravazzola, 1979, Glicentin immunoreactive cells: their relationship to glucagon-producing cells., Endocrinology, 105, 499, 10.1210/endo-105-2-499 · doi:10.1210/endo-105-2-499
- Orci, 1983, Glucagon and glicentin producing cells. In: Lefébre PJ (ed) Glucagon I., Springer, Berlin, vol, 66, 57
- Leduque, 1982, Ontogeny of immunoreactive glicentin in the human gastrointestinal tract and endocrine pancreas., Regul Pept, 4, 261, 10.1016/0167-0115(82)90119-7 · doi:10.1016/0167-0115(82)90119-7
- Saifia, 1998, Galanin inhibits glucagon-like peptide-1 secretion through pertussis toxin-sensitive G protein and ATP-dependent potassium channels in rat ileal L-cells., J Endocrinol, 157, 33, 10.1677/joe.0.1570033 · doi:10.1677/joe.0.1570033
- Philippe, 1995, Islet-specific proteins interact with the insulin-response element of the glucagon gene., J Biol Chem, 270, 3039, 10.1074/jbc.270.7.3039 · doi:10.1074/jbc.270.7.3039
- Rothenberg, 1996, Evidence of redundancy in propeptide/prohormone convertase activities in processing proglucagon: an antisense study., Mol Endocrinol, 10, 331
- Rindi, 1990, Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice., Am J Pathol, 136, 1349
- Wider, 1976, Elevated gut glucagon-like immunoreactive material in human and experimental diabetes and its suppression by somatostatin., Metabolism, 25, 1487, 10.1016/S0026-0495(76)80174-6 · doi:10.1016/s0026-0495(76)80174-6
- O’Connor, 1979, The use of perfused rat intestine to characterize the glucagon-like immunoreactivity released into serosal secretions following stimulation by glucose., Horm Metab Res, 11, 19, 10.1055/s-0028-1092674 · doi:10.1055/s-0028-1092674
- Wojcikowski, 1985, Release of glucagon-like immunoreactive material (GLI) from the isolated perfused jejunum of normal and diabetic rats., Horm Metab Res, 17, 105, 10.1055/s-2007-1013463 · doi:10.1055/s-2007-1013463
- Valverde, 1979, Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and after glucose absorption., Horm Metab Res, 11, 343, 10.1055/s-0028-1092735 · doi:10.1055/s-0028-1092735
- Sasaki, 1993, GLP-1 secretion coupled with Na/glucose transporter from the isolated perfused canine ileum., Digestion, 54, 365
- Barber, 1991, Fatty acids stereospecifically stimulate neurotensin release and increase [Ca2+]i in enteric endocrine cells, Am J Physiol, 261, G497
- Matsuyama, 1975, Glucose, insulin, pancreatic glucagon-like immunoreactive materials in the plasma of normal and diabetic children: effect of the initial insulin treatment., Horm Metab Res, 7, 452, 10.1055/s-0028-1093702 · doi:10.1055/s-0028-1093702
- Barber, 1987, Somatostatin and muscarinic inhibition of canine enteric endocrine cells: cellular mechanisms, Am J Physiol, 253, G684
- Wolfe, 1999, Glucose-dependent insulinotropic polypeptide (GIP): incretin vs. enterogastrone. In: Greeley GH (ed) Gastrointestinal Endocrinology., Humana Press, Totowa, NJ, vol, 8, 439
- Greenberg, 1987, Influence of vagal integrity on gastrin and somatostatin release in dogs., Gastroenterology, 93, 994, 10.1016/0016-5085(87)90561-0 · doi:10.1016/0016-5085(87)90561-0
- Costa, 1982, Neuronal peptides in the intestine., Br Med Bull, 38, 247, 10.1093/oxfordjournals.bmb.a071768 · doi:10.1093/oxfordjournals.bmb.a071768
- Bruzzone, 1983, Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man., J Clin Endocrinol Metab, 56, 643, 10.1210/jcem-56-4-643 · doi:10.1210/jcem-56-4-643
- Sagor, 1985, Influence of somatostatin and bombesin on plasma enteroglucagon and cell proliferation after intestinal resection in the rat., Gut, 26, 89, 10.1136/gut.26.1.89 · doi:10.1136/gut.26.1.89
- Matsuyama, 1980, Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog., Endocrinol Jpn, 27, 115, 10.1507/endocrj1954.27.Supplement_115 · doi:10.1507/endocrj1954.27.supplement_115
- Herrmann, 1993, Regulation of glucagon-like peptide release from the isolated perfused rat ileum by nutrients, peptides and neuromediators., Digestion, 54, 367
- Layer, 1993, GLP-1: a humoral mediator of the ileal brake in humans?, Digestion, 54, 385
- D’Alessio, 1994, Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal., J Clin Invest, 93, 2263, 10.1172/JCI117225 · DOI · Paper page
- Toft-Nielsen, 1996, The effect of GLP-1 on glucose elimination., Diabetes, 45, 552
- Tsai, 1997, Biological determinants of intestinotrophic properties of glucagon-like peptide 1 in vivo, Am J Physiol, 272, G662
- Gros, 1992, Characterization of high affinity receptors for glucagon-like peptide (7-36)amide on a somatostatin-secreting cell line., Biomed Res, 13, 143
- Kanse, 1988, Identification and characterization of glucagon-like peptide-1-7-36 amide in rat brain and lung., FEBS Lett, 267, 78
- Tronier, 1985, Absence of incretin effect in obese type II and diminished effect in lean type II and obese subjects, Diabetes Res Clin Pract, S568
- Habener, 1997, Proglucagon gene structure and regulation of expression. In: Fehmann HC, Göke B (eds) The Insulinotropic Gut Hormone Glucagon-like Peptide-1., Karger, Basel, vol, 13, 15
Cited by
Items 101–122 of 122
Kong, F., Wu, T., Dai, J., Zhai, Z., Cai, J., Zhu, Z., Xu, Y., & Sun, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205207 · Cited by 54
Zhang, H., Liu, Y., Guan, S., Qu, D., Wang, L., Wang, X., Li, X., Zhou, S., Zhou, Y., Wang, N., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148827 · Cited by 50
“Glucagon-like peptide 1 (GLP-1) is a 30-amino acid peptide secreted from the L-cells of the small intestine [2].”
BackgroundZhang, Y. L., Zhou, C., Li, X. F., Yang, M. N., Tao, L., Zheng, X. Y., & Jia, Y. S. (2019) · Obesity Science & Practice · doi:10.1002/osp4.342 · Cited by 49
“This phenomenon of β-cell rest was also observed in previous studies of GLP-1 (7-36) and exendin-4 in the postprandial state (23–25).”
BackgroundResultFarokhnia, M., Browning, B. D., Crozier, M. E., Sun, H., Akhlaghi, F., & Leggio, L. (2022) · Addiction Biology · doi:10.1111/adb.13211 · Cited by 46
Intra-islet glucagon-like peptide 1
Fava, G. E., Dong, E. W., & Wu, H. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.016 · Cited by 45
“…GLP-1 stimulates insulin secretion from islet β cells in a blood-glucose dependent manner, while simultaneously inhibiting glucagon secretion in α cells, thus playing an essential role in blood glucose regulation (Fehmann and Habener 1992; Holst 2007; Kieffer and Habener 1999; Mojsov, et al. 1987).”
BackgroundDirect cardiovascular effects of glucagon like peptide-1
Sheikh, A. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-47 · Cited by 45
“However, unlike GIPR, GLP-1R are present in several other tissues such as peripheral nervous system, lung and heart (Figure 2) [19].”
BackgroundForst, T., Weber, M. M., & Pfützner, A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/635472 · Cited by 44
Nishiyama, Y., Hasegawa, T., Fujita, S., Iwata, N., Nagao, S., Hosoya, T., Inagaki, K., Wada, J., & Otsuka, F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.11.004 · Cited by 43
Acute and repeated restraint differentially activate orexigenic pathways in the rat hypothalamus
Chagra, S. L., Zavala, J. K., Hall, M. V., & Gosselink, K. L. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2010.11.006 · Cited by 35
Chen, Y., Zhang, X., He, J., Xie, Y., & Yang, Y. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.12.015 · Cited by 32
Thombare, K., Ntika, S., Wang, X., & Krizhanovskii, C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177605 · Cited by 32
Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential
AL-Noshokaty, T. M., Abdelhamid, R., Abdelmaksoud, N. M., Khaled, A., Hossam, M., Ahmed, R., Saber, T., Khaled, S., Elshaer, S. S., & Abulsoud, A. I. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101895 · Cited by 30
“Many in vivo and in vitro studies make use of Ex-4, a well-known orthosteric antagonist for the GLP-1R [27].”
Management of type 2 diabetes: the role of incretin mimetics
Stonehouse, A. H., Holcombe, J. H., & Kendall, D. M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.15.2095 · Cited by 29
Ikushima, I., Jensen, L., Flint, A., Nishida, T., Zacho, J., & Irie, S. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0677-1 · Cited by 28
Thyroid safety in patients treated with liraglutide
Gallo, M. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03346749 · Cited by 27
Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus
Forst, T., & Pfützner, A. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838559 · Cited by 25
Dalla Man, C., Micheletto, F., Sathananthan, M., Vella, A., & Cobelli, C. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0146 · Cited by 24
Circulating GLP-1 Levels as a Potential Indicator of Metabolic Syndrome Risk in Adult Women
Seon, M. J., Hwang, S. Y., Son, Y., Song, J., & Kim, O. Y. (2021) · Nutrients · doi:10.3390/nu13030865 · Cited by 21
“When food is ingested, the proglucagon molecules in specific intestinal enterocytes (named L-cells) are cleaved to form amidated peptides that are 30 amino acids in length, named GLP-1(7-36) amide (NH2), the predominant secreted form of GLP-1 which are then secreted into the circulatory system [17].”
BackgroundPharmacogenetics: potential role in the treatment of diabetes and obesity
Vella, A., & Camilleri, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1109 · Cited by 17
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922
“(p M p er 3 0 is le ts ) * e Ctrl Ctrl Ctrl ex (9-39) Ctrl ex (9-39) 30 1.”
Aulinger, B., & D'Alessio, D. (2007) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328013e79e · Cited by 8
Gao, H., Zhao, Q., Li, K., Qin, F., Yin, X., Lu, Z., Song, Z., Wu, Y., Shen, Y., Pan, Y., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112454 · Cited by 3
Metadata
- Authors
- Kieffer, T. J., & Francis Habener, J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1999-12-01
- Volume
- 20
- Issue
- 6
- Pages
- 876-913
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2017518223
- Cited by
- 1,062
- References
- 542
- FWCI
- 21.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.